Skip to Content

1933 Industries Inc TGIFF

Morningstar Rating
$0.01 0.00 (13.64%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TGIFF is trading at a 49% discount.
Price
$0.01
Fair Value
$9.22
Uncertainty
Extreme
1-Star Price
$2.42
5-Star Price
$3.39
Economic Moat
Cczs
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TGIFF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.010.02
Bid/Ask
$0.01 / $0.02
Market Cap
$6.13 Mil
Volume/Avg
82,150 / 85,975

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.36
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
87

Valuation

Metric
TGIFF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.36
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TGIFF
Quick Ratio
0.53
Current Ratio
1.03
Interest Coverage
−6.60
Quick Ratio
TGIFF

Profitability

Metric
TGIFF
Return on Assets (Normalized)
−41.01%
Return on Equity (Normalized)
−1,804.01%
Return on Invested Capital (Normalized)
−42.75%
Return on Assets
TGIFF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AHnksbcvxZkr$70.0 Bil
MKKGY
Merck KGaA ADRGwxcjrsncFgtlfx$68.4 Bil
HLN
Haleon PLC ADRMjmttvhlgYrdn$37.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRWprlvlpyYmwzg$14.5 Bil
VTRS
Viatris IncNmqmnlmrHxj$13.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRSpjnncyBqvy$12.0 Bil
CTLT
Catalent IncRlqdmfgfqBmvly$10.1 Bil
PRGO
Perrigo Co PLCSftyjnchChtm$4.1 Bil
CURLF
Curaleaf Holdings IncKrqfwrnXbhf$3.6 Bil
PBH
Prestige Consumer Healthcare IncFpzpnwqRlrdhqr$3.5 Bil

Sponsor Center